GPR84 and metabolic dysfunction-associated steatohepatitis: In this context, targeting the MCFA receptor GPR84 is quite appealing, as it might represent a more NAFLD-specific pathway for recruiting inflammatory and fibrogenic macrophages to NASH livers.